Literature DB >> 19123478

Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met.

Philip Marx-Stoelting1, Malgorzata Borowiak, Thomas Knorpp, Carmen Birchmeier, Albrecht Buchmann, Michael Schwarz.   

Abstract

The receptor for the hepatocyte growth factor/scatter factor (HGF/SF), c-Met, plays a role in tumour promotion, progression and metastasis. In this study, we analysed chemically induced hepatocarcinogenesis in mice lacking a functional HGF receptor in their liver. Control and c-Met deficient mice were injected with a single dose of N-nitrosodiethylamine (DEN, 90 mICROg/g b.wt.) at 6 weeks of age and mice were subsequently kept on a phenobarbital (PB) containing diet (0.05%) for 35 weeks or on control diet. At the end of the experiment, the carcinogenic response in liver of the animals was monitored. Conditional c-met knockout (KO) mice showed a higher prevalence of macroscopically visible liver tumours and of glutamine synthetase positive and glucose-6-phosphatase deficient lesions in liver. Tumour promotion by PB led to significant increases in the number of preneoplastic and neoplastic lesions in liver of both wild-type and c-met knockout mice, with only minor differences in response. Our results indicate that a defect in c-Met-mediated signaling increases chemically induced tumour initiation in liver but does not significantly affect PB-mediated tumour promotion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19123478     DOI: 10.1002/ijc.24167

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.

Authors:  Yin Zhu; Ming Cheng; Zhen Yang; Chun-Yan Zeng; Jiang Chen; Yong Xie; Shi-Wen Luo; Kun-He Zhang; Shu-Feng Zhou; Nong-Hua Lu
Journal:  Drug Des Devel Ther       Date:  2014-12-09       Impact factor: 4.162

2.  Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.

Authors:  Peyda Korhan; Esra Erdal; Emine Kandemiş; Murat Cokaklı; Deniz Nart; Funda Yılmaz; Alp Can; Neşe Atabey
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

3.  HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.

Authors:  Hara Afaloniati; Katerina Angelopoulou; Alexander Giakoustidis; Alexandros Hardas; Athanasios Pseftogas; Kali Makedou; Athanasios Gargavanis; Thomas Goulopoulos; Stavros Iliadis; Vasileios Papadopoulos; Apostolos Papalois; George Mosialos; Theofilos Poutahidis; Dimitrios Giakoustidis
Journal:  Onco Targets Ther       Date:  2020-06-15       Impact factor: 4.147

4.  Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.

Authors:  Kojiro Matsumoto; Jiansheng Huang; Navin Viswakarma; Liang Bai; Yuzhi Jia; Yiwei Tony Zhu; Gongshe Yang; Jayme Borensztajn; M Sambasiva Rao; Yi-Jun Zhu; Janardan K Reddy
Journal:  Carcinogenesis       Date:  2009-12-09       Impact factor: 4.944

5.  Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Authors:  Evin Ozen; Aysim Gozukizil; Esra Erdal; Aykut Uren; Donald P Bottaro; Nese Atabey
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

6.  Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.

Authors:  Giray Bozkaya; Peyda Korhan; Murat Cokaklı; Esra Erdal; Ozgül Sağol; Sedat Karademir; Christopher Korch; Neşe Atabey
Journal:  Mol Cancer       Date:  2012-09-11       Impact factor: 27.401

7.  Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.

Authors:  Zeynep Firtina Karagonlar; Dogukan Koc; Evin Iscan; Esra Erdal; Neşe Atabey
Journal:  Cancer Sci       Date:  2016-02-23       Impact factor: 6.716

Review 8.  c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.

Authors:  Alessandro Granito; Elena Guidetti; Laura Gramantieri
Journal:  J Hepatocell Carcinoma       Date:  2015-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.